Search results for "health resources"

showing 10 items of 18 documents

Resources to cope with stigma related to HIV status, gender identity, and sexual orientation in gay men and transgender women

2017

The stigma related to HIV status, gender identity, and sexual orientation has negative implications for the quality of life of individuals. A qualitative study was conducted to explore the resources that these stigmatized groups recognize as tools to cope with stigma and maintain their psychological well-being. Four focus groups were conducted with gay men and transgender women divided by HIV status. A thematic analysis revealed that individual, interpersonal, and institutional resources are commonly recognized as coping resources. This article discusses the importance of enhancing self-acceptance, social support, and a legal framework that legitimizes these groups as right holders.

AdultMaleAdolescentHuman RightsSexual BehaviorSocial StigmaHIV InfectionsInterpersonal communicationTransgender PersonsYoung Adult03 medical and health sciencesSocial support0302 clinical medicineAdaptation PsychologicalHumans030212 general & internal medicineHomosexuality MaleQualitative ResearchApplied Psychology030505 public healthGender IdentitySocial SupportFocus GroupsMiddle AgedFocus groupPsychological well-beingQuality of LifeSexual orientationHealth ResourcesFemaleThematic analysisLesbian0305 other medical sciencePsychologySocial psychologyClinical psychologyQualitative researchJournal of Health Psychology
researchProduct

Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study

2018

National audience; Les aidants familiaux jouent un rôle central auprès des patients présentant un cancer de stade avancé. Parmi les proches susceptibles d’apporter une aide aux personnes malades, les conjoints, en raison des liens qui les unissent et parce qu’ils partagent leur vie quotidienne, sont sans doute les plus confrontés à la maladie. Ils sont également majoritairement désignés comme étant l’aidant principal. L’irruption de la maladie et le besoin d’accompagnement qu’elle nécessite, viennent bouleverser en profondeur les différents équilibres structurant leur quotidien et leur organisation. Ils viennent aussi questionner la nature des relations qu’ils entretiennent, dans une divers…

AdultMaleColorectal cancerHealth PersonnelEmotions[SHS.PSY]Humanities and Social Sciences/Psychology[SDV.CAN]Life Sciences [q-bio]/Cancer[SHS.PSY] Humanities and Social Sciences/Psychology03 medical and health sciences0302 clinical medicineNursingMedicineHumans030212 general & internal medicineQualitative ResearchCancer[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyFamily caregiversbusiness.industryNursing researchSkillsFocus GroupsMiddle Agedmedicine.diseaseFocus groupAdvanced cancer3. Good healthIdentification (information)Cross-Sectional StudiesOncologyCaregivers[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie030220 oncology & carcinogenesisColonic NeoplasmsHealth Resources[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleClinical CompetenceFranceDependantbusinessQualitative[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyQualitative research
researchProduct

Incidence, Medical Resource Utilisation and Costs of Hyperuricemia and Tumour Lysis Syndrome in Patients with Acute Leukaemia and Non-Hodgkin's Lymph…

2003

Hyperuricemia (HU) and tumour lysis syndrome (TLS) are complications of acute leukaemia and non-Hodgkin lymphoma (NHL) leading to increased morbidity and mortality. The objective of this study was to define incidence and calculate health care cost associated with HU and TLS. 788 acute leukaemia and NHL patients from Belgium, The Netherlands, Spain and UK were screened retrospectively for HU and TLS. Resource use related to HU and TLS was recorded and costs were calculated applying local unit costs. Results showed that HU occurred in 18.9% of patients, and 27.8% of them fulfilled TLS criteria. The cost of HU without TLS was 672 euros (SE 181), the cost of TLS 7,342 euros (SE 1,412). TLS requ…

Cancer Researchmedicine.medical_specialtyPediatricsmedicine.medical_treatmentHyperuricemiaRenal DialysisRisk FactorsIntensive caremedicineRasburicaseHumansHyperuricemiaChildhealth care economics and organizationsDialysisNetherlandsLeukemiabusiness.industryIncidenceLymphoma Non-HodgkinIncidence (epidemiology)Age FactorsDisease ManagementHealth Care CostsHematologyMiddle Agedmedicine.diseaseUnited KingdomLymphomaSurgeryNon-Hodgkin's lymphomaTumor lysis syndromeOncologySpainAcute DiseaseHealth ResourcesTumor Lysis Syndromebusinessmedicine.drugLeukemia & Lymphoma
researchProduct

Ranking of Palliative Care Development in the Countries of the European Union.

2016

Abstract Context There is growing interest in monitoring palliative care (PC) development internationally. One aspect of this is the ranking of such development for comparative purposes. Objectives To generate a ranking classification and to compare scores for PC development in the countries of the European Union, 2007 and 2013. PC "development" in this study is understood as a combination of the existence of relevant services in a country ("resources") plus the capacity to develop further resources in the future ("vitality"). Methods "Resources" comprise indicators of three types of PC services per population (inpatient palliative care units and inpatient hospices, hospital support teams, …

Economic growthPalliative carePopulationNursing(all)Clinical NeurologyContext (language use)VitalityRanking (information retrieval)03 medical and health sciences0302 clinical medicineMedicineRaw scoremedia_common.cataloged_instanceHumans030212 general & internal medicineEuropean UnionEuropean unioneducationdevelopmentGeneral NursingAccreditationmedia_commoneducation.field_of_studybusiness.industryPalliative CareEuropeAnesthesiology and Pain Medicine030220 oncology & carcinogenesisHealth ResourcesNeurology (clinical)RankingbusinessJournal of pain and symptom management
researchProduct

What is the impact of rerouting a cancer diagnosis from emergency presentation to GP referral on resource use and survival? Evidence from a populatio…

2018

Background Studies on alternative routes to diagnosis stimulated successful policy interventions reducing the number of emergency diagnoses and associated mortality risk. A dearth of evidence on the costs of such interventions might prevent new policies from achieving more ambitious targets. Methods We conducted a retrospective cohort study on the population of colorectal (88,051), breast (90,387), prostate (96,219), and lung (97,696) cancer patients diagnosed after a GP referral or an emergency presentation and reported in the Cancer Registry of England. Resource use and survival were compared 1 year before and 5 years after diagnosis (3 years for lung), including the costs of GP referrals…

Emergency Medical ServicesCancer ResearchSurvival0302 clinical medicineNeoplasmsEmergency medical services1306030212 general & internal medicineMedical diagnosisReferral and Consultationeducation.field_of_study1311Health Care CostsEarly diagnosilcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisEarly diagnosisPrimary careRoute to diagnosisRoute to diagnosiOncologyPopulation Surveillance030220 oncology & carcinogenesisHealth ResourcesHospital costResearch Articlemedicine.medical_specialty2730ReferralEarly diagnosis; Emergency; Hospital costs; Primary care; Route to diagnosis; Survival; Oncology; Genetics; Cancer ResearchPopulationlcsh:RC254-28203 medical and health sciencesGeneticGeneral PractitionersGeneticsmedicineHumanseducationLung cancerbusiness.industryCancerRetrospective cohort studymedicine.diseaseCancer registryEmergency medicineEmergencyHospital costsbusinessNeoplasms/diagnosis
researchProduct

Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteo…

2016

The Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC-OS) is a prospective, observational study of women with osteoporosis in Europe and Canada. At baseline, patients with gastrointestinal symptoms reported lower adherence to osteoporosis treatment, treatment satisfaction, and health-related quality of life, than those without gastrointestinal symptoms. INTRODUCTION: The aim of the study was to examine gastrointestinal (GI) symptoms and the association between GI symptoms and treatment adherence, treatment satisfaction, and health-related quality of life (HRQoL) among osteoporotic women in Europe and Canada. METHODS: Baseline results are re…

Gastrointestinal DiseasesEndocrinology Diabetes and MetabolismHealth-related quality of lifeOsteoporosisFRACTURE RISKRISEDRONATE0302 clinical medicineEndocrinologyQuality of lifeBack pain030212 general & internal medicineProspective StudiesHEALTH PLANProspective cohort studyALENDRONATEOsteoporosis PostmenopausalPOPULATIONeducation.field_of_studyBone Density Conservation AgentsDiphosphonatesBISPHOSPHONATE THERAPYSettore MED/34 - Medicina Fisica E RiabilitativaTRACT SAFETYBisphosphonatesMiddle AgedEuropeDiabetes and MetabolismPOSTMENOPAUSAL WOMENPatient SatisfactionHealth ResourcesFemaleOriginal ArticlePostmenopausalmedicine.symptomBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Aged; Bone Density Conservation Agents; Canada; Diphosphonates; Europe; Female; Gastrointestinal Diseases; Health Resources; Humans; Medication Adherence; Middle Aged; Osteoporosis Postmenopausal; Patient Satisfaction; Prospective Studies; Psychometrics; Quality of Life; Endocrinology Diabetes and Metabolismmedicine.medical_specialtyCanadaGastrointestinalPsychometricsPopulation030209 endocrinology & metabolismNOMedication Adherence03 medical and health sciencesInternal medicinemedicineHumanseducationBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Aged; Bone Density Conservation Agents; Canada; Diphosphonates; Europe; Female; Gastrointestinal Diseases; Health Resources; Humans; Medication Adherence; Middle Aged; Osteoporosis Postmenopausal; Patient Satisfaction; Prospective Studies; Psychometrics; Quality of LifeAgedTreatment satisfactionbusiness.industryPERSISTENCEbisphosphonates gastrointestyinal osteoporosis postmenopausal treatment satisfactionBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfactionmedicine.diseaseRheumatologyCLINICAL-PRACTICEOrthopedic surgeryQuality of LifeOsteoporosisObservational studybusinessBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Endocrinology Diabetes and Metabolism
researchProduct

Suitability of the health and social care resources for persons requiring long-term care in Spain: An empirical approach

2004

Abstract The objective of this paper is to examine the suitability of specific facilities for dependent persons for meeting users’ needs. A total of 1265 users of social and health facilities for dependent persons were interviewed in a study carried out in a typical southern European region with a Mediterranean welfare system: the Valencia Autonomous Region in Spain. Data were obtained on users’ socio-demographic profile, health, functional dependence, cognition, social support and housing suitability. Based on these data and the institutional definitions of the specific facilities for dependent persons, the suitability index was drawn up for each facility and suitability was evaluated usin…

GerontologySocial WorkIndex (economics)business.industryHealth PolicyEmpirical ResearchMiddle AgedEuropean regionLong-Term CareNursing HomesInterviews as TopicLong-term careSocial supportWelfare systemSpainHealth ResourcesHumansMedicineSocial carebusinessAgedProgram EvaluationHealth Policy
researchProduct

Understanding frailty:a qualitative study of European healthcare policy-makers' approaches to frailty screening and management

2018

ObjectiveTo elicit European healthcare policy-makers’ views, understanding and attitudes about the implementation of frailty screening and management strategies and responses to stakeholders’ views.DesignThematic analysis of semistructured qualitative interviews.SettingEuropean healthcare policy departments.ParticipantsSeven European healthcare policy-makers representing the European Union (n=2), UK (n=2), Italy (n=1), Spain (n=1) and Poland (n=1). Participants were sourced through professional networks and the European Commission Authentication Service website and were required to be in an active healthcare policy or decision-making role.ResultsSeven themes were identified. Our findings re…

Health Knowledge Attitudes PracticeService (systems architecture)Attitude of Health PersonnelFrail ElderlyDecision MakingGeriatric MedicinefrailtySocial Environmentseniors03 medical and health sciences0302 clinical medicineConsistency (negotiation)Nursing030502 gerontologyHealth careHumansmedia_common.cataloged_instanceMedicineEuropean Union030212 general & internal medicine1506European union1329Policy MakingQualitative ResearchAgedmedia_commonAged 80 and overbusiness.industry1698Health PolicyResearchAdministrative PersonnelCorrectionSocial environmentGeneral MedicineOrganizational CultureIntegrated careEuropeageingHealth ResourcesThematic analysis0305 other medical sciencebusinessDelivery of Health CareQualitative research
researchProduct

Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy

2020

Abstract Background and aims Nonalcoholic steatohepatitis (NASH) may progress to advanced liver disease (AdvLD). This study characterized comorbidities, healthcare resource utilization (HCRU) and associated costs among hospitalized patients with AdvLD due to NASH in Italy. Methods and results Adult nonalcoholic fatty liver disease (NAFLD)/NASH patients from 2011 to 2017 were identified from administrative databases of Italian local health units using ICD-9-CM codes. Development of compensated cirrhosis (CC), decompensated cirrhosis (DCC), hepatocellular carcinoma (HCC), or liver transplant (LT) was identified using first diagnosis date for each severity cohort (index-date). Patients progres…

Liver CirrhosisMaleTime FactorsCirrhosisDatabases FactualEndocrinology Diabetes and MetabolismMedicine (miscellaneous)ComorbidityHospital Cost030204 cardiovascular system & hematologyLiver diseasePatient Admission0302 clinical medicineRetrospective StudieNon-alcoholic Fatty Liver DiseaseRisk FactorsNonalcoholic fatty liver diseaseAmbulatory CarePrevalenceMedicineHospital Costseducation.field_of_studyDrug CostNutrition and DieteticsLiver NeoplasmsNASHMiddle AgedPrognosisItalyLiver NeoplasmHepatocellular carcinomaCohortDisease ProgressionHealth ResourcesFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyCarcinoma HepatocellularTime FactorAdolescentCostPrognosiLiver CirrhosiPopulation030209 endocrinology & metabolismPharmacyDrug CostsYoung Adult03 medical and health sciencesNAFLDInternal medicineHumanseducationAgedRetrospective StudiesHealth Resourcebusiness.industryRisk Factormedicine.diseaseComorbiditydigestive system diseasesLiver TransplantationHCRUbusinessAdministrative Claims HealthcareNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014

2018

The cost of cancer and outcomes of cancer care have been discussed a lot since cancer represents 3-6% of total healthcare costs and cost estimations have indicated growing costs. There are studies considering the cost of all cancers, but studies focusing on the cost of disease and outcomes in most common cancer sites are limited. The objective of this study was to analyze the development of the costs and outcomes in Finland between 2009 and 2014 per cancer site.The National cost, episode and outcomes data were obtained from the National register databases based on International Statistical Classification of Diseases (ICD)-10 diagnosis codes. Cost data included both the direct and indirect c…

MaleENGLANDTreatment outcomesairaalahoitocosts0302 clinical medicineFinnish populationavohoitoNeoplasmsHealth careRegistries030212 general & internal medicineta512Finlandhealth care economics and organizationsta316Aged 80 and overnon-institutional careNeoplasms therapyta3142Health Care CostsHematologyGeneral MedicineMiddle Agedkustannukset3. Good healthSurvival RateTreatment OutcomeOncology030220 oncology & carcinogenesisNORWAYSURVIVALHealth ResourcessyöpätauditFemaleSick LeaveCOUNTRIESAdultsairaalatmedicine.medical_specialtyMEDLINEUNITED-STATEShoito03 medical and health sciencesBreast cancerSuomiECONOMIC BURDENmedicineBREAST-CANCERHumansRadiology Nuclear Medicine and imagingIntensive care medicineSurvival rateAgedbusiness.industryCancercancerous diseasesCAREta3122medicine.diseasehospitalsbusinesshospital careActa Oncologica
researchProduct